169 related articles for article (PubMed ID: 36875116)
21. Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study.
Fu Z; Li X; Zhong J; Chen X; Cao K; Ding N; Liu L; Zhang X; Zhai J; Qu Z
Hepatol Int; 2021 Jun; 15(3):663-675. PubMed ID: 33877527
[TBL] [Abstract][Full Text] [Related]
22. Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors.
Xiong B; Fu B; Wu Y; Gao F; Hou C
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11607-11617. PubMed ID: 37400572
[TBL] [Abstract][Full Text] [Related]
23. A novel nomogram to predict survival of patients with hepatocellular carcinoma after transarterial chemoembolization: a tool for retreatment decision making.
Li J; Li C; Zhu G; Yang J; Zhang Y; Yu Z; Xia J
Ann Transl Med; 2023 Jan; 11(2):68. PubMed ID: 36819596
[TBL] [Abstract][Full Text] [Related]
24. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
[TBL] [Abstract][Full Text] [Related]
25. Prognostic nomogram predicting survival of patients with unresectable hepatocellular carcinoma after hepatic arterial infusion chemotherapy.
Mei J; Lin WP; Shi F; Wei W; Liang JB; Shi M; Zheng L; Li SH; Guo RP
Eur J Radiol; 2021 Sep; 142():109890. PubMed ID: 34375811
[TBL] [Abstract][Full Text] [Related]
26. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study.
Chen R; Li L; Li Y; Song K; Shen C; Ma P; Wang Z
J Gastrointest Oncol; 2022 Jun; 13(3):1367-1375. PubMed ID: 35837188
[TBL] [Abstract][Full Text] [Related]
28. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
Jing CY; Fu YP; Zheng SS; Yi Y; Shen HJ; Huang JL; Xu X; Lin JJ; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
Medicine (Baltimore); 2017 Mar; 96(11):e6140. PubMed ID: 28296727
[TBL] [Abstract][Full Text] [Related]
29. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
[TBL] [Abstract][Full Text] [Related]
30. Nomogram for predicting pathologic complete response after transarterial chemoembolization in patients with hepatocellular carcinoma.
Lin J; Li X; Shi X; Zhang L; Liu H; Liu J; Wang K; Shen F
Ann Transl Med; 2021 Jul; 9(14):1130. PubMed ID: 34430571
[TBL] [Abstract][Full Text] [Related]
31. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
32. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
33. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
[TBL] [Abstract][Full Text] [Related]
34. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
[TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of transarterial chemoembolization in downstaging unresectable hepatocellular carcinoma to curative therapy: a predicted regression model.
Lin H; Luo B; Peng F; Fang C; Gan Y; Yang X; Li B; Li Y; Su S
Invest New Drugs; 2022 Oct; 40(5):1146-1152. PubMed ID: 35723760
[TBL] [Abstract][Full Text] [Related]
37. Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A review.
Sun L; Xu X; Meng F; Liu Q; Wang H; Li X; Li G; Chen F
Front Oncol; 2022; 12():980214. PubMed ID: 36249023
[TBL] [Abstract][Full Text] [Related]
38. The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.
Cao F; Yang Y; Si T; Luo J; Zeng H; Zhang Z; Feng D; Chen Y; Zheng J
Front Oncol; 2021; 11():783480. PubMed ID: 34988019
[TBL] [Abstract][Full Text] [Related]
39. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
40. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma.
Niu XK; He XF
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]